Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Bristol-Myers Squibb Co. (NYSE:BMY) is an American multinational biopharmaceutical company that develops, manufactures, and markets innovative medicines to help patients with serious diseases. It will report its Q3 2025 earnings on Oct. 30. Wall Street analysts expect the company to post EPS of $1.67, down from$1.80 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expect ...